In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.

M.T. Illnait-Zaragozi; G.F. Martinez; I. Curfs-Breuker; C.M. Fernandez-Andreu; T. Boekhout; J.F. Meis

doi:10.1128/AAC.01384-07

In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.

M.T. Illnait-Zaragozi, G.F. Martinez, I. Curfs-Breuker, C.M. Fernandez-Andreu, T. Boekhout, J.F. Meis

Onderzoeksoutput: Bijdrage aan wetenschappelijk tijdschrift/periodieke uitgave › Artikel › Wetenschappelijk › peer review

70 Citaten (Scopus)

Samenvatting

Cuban Cryptococcus isolates (n = 165) were tested in vitro against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole, giving MIC90 values of 0.25, 8, 4, 0.25, 0.125, 0.016, and 0.016 microg/ml, respectively. Isavuconazole and posaconazole seem to be potentially active drugs for treating cryptococcal infections.

Originele taal-2	Engels
Pagina's (van-tot)	1580-1582
Tijdschrift	Antimicrobial Agents and Chemotherapy
Volume	52
Nummer van het tijdschrift	4
DOI's	https://doi.org/10.1128/AAC.01384-07
Status	Gepubliceerd - 2008

Toegang tot document

10.1128/AAC.01384-07

Citeer dit

Illnait-Zaragozi, M. T., Martinez, G. F., Curfs-Breuker, I., Fernandez-Andreu, C. M., Boekhout, T., & Meis, J. F. (2008). In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrobial Agents and Chemotherapy, 52(4), 1580-1582. https://doi.org/10.1128/AAC.01384-07

@article{803503122dad40ec9277d56f1ad989b4,

title = "In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.",

abstract = "Cuban Cryptococcus isolates (n = 165) were tested in vitro against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole, giving MIC90 values of 0.25, 8, 4, 0.25, 0.125, 0.016, and 0.016 microg/ml, respectively. Isavuconazole and posaconazole seem to be potentially active drugs for treating cryptococcal infections.",

author = "M.T. Illnait-Zaragozi and G.F. Martinez and I. Curfs-Breuker and C.M. Fernandez-Andreu and T. Boekhout and J.F. Meis",

note = "Reporting year: 2008",

year = "2008",

doi = "10.1128/AAC.01384-07",

language = "English",

volume = "52",

pages = "1580--1582",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "4",

}

Illnait-Zaragozi, MT, Martinez, GF, Curfs-Breuker, I, Fernandez-Andreu, CM, Boekhout, T & Meis, JF 2008, 'In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.', Antimicrobial Agents and Chemotherapy, vol. 52, nr. 4, blz. 1580-1582. https://doi.org/10.1128/AAC.01384-07

In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. / Illnait-Zaragozi, M.T.; Martinez, G.F.; Curfs-Breuker, I. et al.
In: Antimicrobial Agents and Chemotherapy, Vol. 52, Nr. 4, 2008, blz. 1580-1582.

Onderzoeksoutput: Bijdrage aan wetenschappelijk tijdschrift/periodieke uitgave › Artikel › Wetenschappelijk › peer review

TY - JOUR

T1 - In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.

AU - Illnait-Zaragozi, M.T.

AU - Martinez, G.F.

AU - Curfs-Breuker, I.

AU - Fernandez-Andreu, C.M.

AU - Boekhout, T.

AU - Meis, J.F.

N1 - Reporting year: 2008

PY - 2008

Y1 - 2008

N2 - Cuban Cryptococcus isolates (n = 165) were tested in vitro against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole, giving MIC90 values of 0.25, 8, 4, 0.25, 0.125, 0.016, and 0.016 microg/ml, respectively. Isavuconazole and posaconazole seem to be potentially active drugs for treating cryptococcal infections.

AB - Cuban Cryptococcus isolates (n = 165) were tested in vitro against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole, giving MIC90 values of 0.25, 8, 4, 0.25, 0.125, 0.016, and 0.016 microg/ml, respectively. Isavuconazole and posaconazole seem to be potentially active drugs for treating cryptococcal infections.

U2 - 10.1128/AAC.01384-07

DO - 10.1128/AAC.01384-07

M3 - Article

SN - 0066-4804

VL - 52

SP - 1580

EP - 1582

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 4

ER -

In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit